| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/26/2015 | WO2015025001A1 Method for production of concentrates of preferably water-soluble active agents |
| 02/26/2015 | WO2015025000A1 Pharmaceutical compositions comprising bortezomib |
| 02/26/2015 | WO2015024759A1 Process for preparing redispersible powders of water-insoluble, biodegradable polyesters |
| 02/26/2015 | WO2015024512A1 Use of icaritin in preparation of drugs for treatment of diseases related to flt-3 |
| 02/26/2015 | WO2015024218A1 Pharmaceutical composition, preparation method therefor and use thereof |
| 02/26/2015 | WO2015024217A1 Chlorogenic acid powder-injection and preparation method thereof |
| 02/26/2015 | US20150057605 Stable Glucagon Peptide Formulations |
| 02/26/2015 | US20150057371 Reversible, on-demand generation of aqueous two-phase microdroplets |
| 02/26/2015 | US20150057368 Closed cell foams including poly-4-hydroxybutyrate and copolymers thereof |
| 02/26/2015 | US20150057362 Effective Sensitizing Dose of a Gelled Immunomodulating Topical Composition |
| 02/26/2015 | US20150057360 Methods for the treatment of tinnitus induced by cochlear excitotoxicity |
| 02/26/2015 | US20150057358 Novel sustained release dosage forms |
| 02/26/2015 | US20150057356 Melt-extruded composition comprising a cellulose ether |
| 02/26/2015 | US20150057355 Amantadine compositions and methods of use |
| 02/26/2015 | US20150057343 AGONISTS OF THE AhR RECEPTOR PATHWAY HAVING SEBOSUPPRESSIVE ACTIVITY AND A METHOD FOR IDENTIFYING SAID AGONISTS |
| 02/26/2015 | US20150057342 Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
| 02/26/2015 | US20150057327 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 02/26/2015 | US20150057324 Tablet containing 5-hydroxy-1h-imidazole-4-carboxamide |
| 02/26/2015 | US20150057323 Composition for treating ocular effects of diabetes |
| 02/26/2015 | US20150057321 Soft chewable pharmaceutical products |
| 02/26/2015 | US20150057304 Extruded Immediate Release Abuse Deterrent Pill |
| 02/26/2015 | US20150057287 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
| 02/26/2015 | US20150057284 Method and improved pharmaceutical composition for enhancing transdermal delivery of pde-5 inhibitor |
| 02/26/2015 | US20150057273 Kinase inhibitors |
| 02/26/2015 | US20150057266 Pharmaceutical Composition Having Improved Dissolution Profiles For Poorly Soluble Drugs |
| 02/26/2015 | US20150057259 Stabilized compositions containing alkaline labile drugs |
| 02/26/2015 | US20150057252 Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate |
| 02/26/2015 | US20150056313 Composition and Method for Inhibiting Herpesviridae Infections |
| 02/26/2015 | US20150056295 Cellular extracts |
| 02/26/2015 | US20150056294 Methods and compositions for preparing a silk microsphere |
| 02/26/2015 | US20150056293 Silk nanospheres and microspheres and methods of making same |
| 02/26/2015 | US20150056292 Joint Product Comprising Synephrine and Topiramate |
| 02/26/2015 | US20150056290 Microsphere compositions, preparation method and applications thereof |
| 02/26/2015 | US20150056287 Nanoparticulate megestrol formulations |
| 02/26/2015 | US20150056286 Nanoparticulate megestrol formulations |
| 02/26/2015 | US20150056285 Sustained release formulations using non-aqueous carriers |
| 02/26/2015 | US20150056284 Pharmaceutical composition |
| 02/26/2015 | US20150056283 Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury |
| 02/26/2015 | US20150056280 Isotopologues of 5-azacytidine |
| 02/26/2015 | US20150056279 Controlled Release and Taste Masking Oral Pharmaceutical Compositions |
| 02/26/2015 | US20150056278 Direct Compression Polymer Tablet Core |
| 02/26/2015 | US20150056277 Drug delivery system |
| 02/26/2015 | US20150056275 Controlled-release solid dosage forms of mesalamine |
| 02/26/2015 | US20150056273 Microbubble ultrasound contrast agent for external use |
| 02/26/2015 | US20150056272 Synergistic Antimicrobial Preparations Containing Chlorite and Hydrogen Peroxide |
| 02/26/2015 | US20150056269 Liposome comprising at least one cholesterol derivative |
| 02/26/2015 | US20150056268 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| 02/26/2015 | US20150056263 Implantable meshes for controlling the movement of fluids |
| 02/26/2015 | US20150056255 Product Comprising a Plant for Medicinal, Cosmetic, Coloring or Dermatologic Use |
| 02/26/2015 | US20150056181 Nanocarriers with multi-photon response elements |
| 02/26/2015 | US20150056175 Composition for preventing and/or treating dermatosis and method for obtaining same |
| 02/26/2015 | US20150056149 Topical tetracycline compositions |
| 02/26/2015 | US20150056145 Magnetic nanoparticle-samirna complex and method for preparing same |
| 02/26/2015 | US20150056140 Electrolyte purgatives |
| 02/25/2015 | EP2839877A1 Method for the production of concentrates, preferably of water-soluble agents |
| 02/25/2015 | EP2839835A1 Encapsulated formulation |
| 02/25/2015 | EP2839834A1 Dermatological composition comprising plant stem cells and a derivate of salicylic acid |
| 02/25/2015 | EP2839830A1 Kits and compositions for treating lower urinary tract disorders |
| 02/25/2015 | EP2839829A1 Sustained release tablet containing levodropropizine and method for preparing same |
| 02/25/2015 | EP2839828A1 Compunds and formulations for the treatment of wounds |
| 02/25/2015 | EP2839015A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids |
| 02/25/2015 | EP2838563A1 Compositions and methods comprising energy absorbing materials for follicular delivery |
| 02/25/2015 | EP2838553A1 Growth enhancement of infants |
| 02/25/2015 | EP2838537A2 Compositions and methods comprising celecoxib or related compounds and dextromethorphan |
| 02/25/2015 | EP2838536A1 Immediate release pharmaceutical compositions with abuse deterrent properties |
| 02/25/2015 | EP2838525A1 Fatty acid derivative-polymer conjugate |
| 02/25/2015 | EP2838524A1 Compositions for topical treatment of microbial infections |
| 02/25/2015 | EP2838518A1 Method of treating acne |
| 02/25/2015 | EP2838517A1 Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| 02/25/2015 | EP2838516A1 Immediate release, abuse deterrent pharmaceutical compositions |
| 02/25/2015 | EP2838515A1 Mesoporous silica compositions for modulating immune responses |
| 02/25/2015 | EP2838514A1 Pellets comprising high active ingredient content |
| 02/25/2015 | EP2838513A1 Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole |
| 02/25/2015 | EP2838512A1 Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
| 02/25/2015 | EP2838511A1 Ocular drug delivery system |
| 02/25/2015 | EP2838510A1 Atomoxetine solution |
| 02/25/2015 | EP2838509A1 Formulations and methods for treatment of inflammatory skin diseases |
| 02/25/2015 | EP2838508A1 Formulations and methods for treatment of acne and inflammatory skin conditions |
| 02/25/2015 | EP2838507A1 Matrix and device and use thereof for optically-controlled release of chemicals |
| 02/25/2015 | EP2838506A1 Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| 02/25/2015 | EP2838505A1 Combination of a non-steroidal anti-inflammatory drug with an anti-histaminic drug intended for ophthalmic use |
| 02/25/2015 | EP2838372A2 Remelted ingestible products |
| 02/24/2015 | US8962700 Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures |
| 02/24/2015 | US8962699 Liquid composition to be filled in soft capsules |
| 02/24/2015 | US8962696 Microemulsion preparation of high concentration propofol for anesthetic uses |
| 02/24/2015 | US8962686 Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| 02/24/2015 | US8962673 Use of melatonin for treating and/or preventing mucositis |
| 02/24/2015 | US8962669 Antimycotic pharmaceutical composition |
| 02/24/2015 | US8962666 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint |
| 02/24/2015 | US8962658 Fluoralkylcarbonyl-oxadiazoles |
| 02/24/2015 | US8962649 Multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical |
| 02/24/2015 | US8962632 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 02/24/2015 | US8962601 Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroids |
| 02/24/2015 | US8962595 Compositions of small molecule therapeutics |
| 02/24/2015 | US8962577 Controlled release formulations for the delivery of HIF-1 inhibitors |
| 02/24/2015 | US8962572 Bortezomib formulations |
| 02/24/2015 | US8962568 Treatment of T-cell mediated diseases |
| 02/24/2015 | US8962559 Sustained release formulations comprising GNRH analogues |
| 02/24/2015 | US8962548 Multi-component biological transport systems |
| 02/24/2015 | US8962316 Choroid plexus device |